These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 4043202)

  • 21. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in metabolism and urinary excretion of antipyrine induced by aerobic conditioning.
    Villa JG; Bayon JE; González-Gallego J
    J Sports Med Phys Fitness; 1999 Sep; 39(3):197-201. PubMed ID: 10573660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of enzyme induction on antipyrine metabolite formation.
    Danhof M; Verbeek RM; van Boxtel CJ; Boeijinga JK; Breimer DD
    Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical exercise and improvement of liver oxidative metabolism in the elderly.
    Mauriz JL; Tabernero B; García-López J; Jorquera F; Villa JG; González-Gallego J
    Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of alaproclate on antipyrine metabolite formation in man.
    Teunissen MW; Wahlén A; Vinnars E; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(4):447-52. PubMed ID: 6519152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assay of antipyrine and its main metabolites 3-hydroxymethylantipyrine, norantipyrine and 4-hydroxyantipyrine in urine.
    Brendel E; Meineke I; de Mey C
    J Pharm Biomed Anal; 1989; 7(12):1783-90. PubMed ID: 2490567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of antipyrine and metabolites in plasma of a patient with mild renal failure.
    Lanchote VL; Ping WC; Santos SR
    Ther Drug Monit; 1997 Dec; 19(6):705-10. PubMed ID: 9421115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma concentration-response relationship for cimetidine inhibition of drug metabolism in the rat.
    Adedoyin A; Aarons L; Houston JB
    Drug Metab Dispos; 1987; 15(1):127-32. PubMed ID: 2881749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition of antipyrine in patients with extensive metastatic liver disease.
    Robertz-Vaupel GM; Lindecken KD; Edeki T; Funke C; Belwon S; Dengler HJ
    Eur J Clin Pharmacol; 1992; 42(5):465-9. PubMed ID: 1606991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment.
    Teunissen MW; Willemse PH; Sleijfer DT; Sluiter WJ; Breimer DD
    Cancer Chemother Pharmacol; 1984; 13(3):181-5. PubMed ID: 6207949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of antipyrine and sulphadimidine in dwarf goats: effects of the enzyme-inducing agents phenobarbital, troleandomycin and rifampicin.
    Natsuhori M; Witkamp RF; Van 't Klooster GA; Van Miert AS
    Xenobiotica; 1992 Nov; 22(11):1243-50. PubMed ID: 1492417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
    van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
    Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of dietary restriction on the metabolism of theophylline and antipyrine in the ageing female BN/BiRij rat.
    Groen K; Breimer DD; Brouwer A; Schijff G; Jansen EJ; van Bezooijen CF
    J Pharmacol Exp Ther; 1995 Jul; 274(1):143-7. PubMed ID: 7616391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.
    Shaw PN; Houston JB; Rowland M; Hopkins K; Thiercelin JF; Morselli PL
    Br J Clin Pharmacol; 1985 Dec; 20(6):611-8. PubMed ID: 4091993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of renal failure on cytochrome P450 activity in hypertensive patients using a "cocktail" of antipyrine and nifedipine.
    Lanchote VL; Ping WC; Santos SR
    Eur J Clin Pharmacol; 1996; 50(1-2):83-9. PubMed ID: 8739816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
    Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
    Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of short-term water deprivation on antipyrine disposition in calves.
    Janus K; Muszczynski Z; Suszycka J
    Res Vet Sci; 1997; 63(1):1-3. PubMed ID: 9368948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.
    Palette C; Cordonnier P; Naline E; Advenier C; Pays M
    J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
    Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
    Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach.
    Schellens JH; Janssens AR; van der Wart JH; van der Velde EA; Breimer DD
    Eur J Clin Invest; 1989 Oct; 19(5):472-9. PubMed ID: 2511024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.